Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Vitae Pharmaceuticals, Inc (VTAE)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 6133.0% | 222.7% | 66.3% | 71.3% |
| General and administrative | 1607.5% | 91.3% | 24.0% | 22.0% |
| Depreciation | 37.9% | 2.5% | 0.9% | 2.4% |
| EBIT | -7640.5% | -214.0% | 9.7% | 6.7% |
| Pre-tax income | -7587.5% | -220.4% | 5.2% | 1.0% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -7587.5% | -220.4% | 5.2% | 1.0% |
|